Pediatric Clinics of North America - CIPERJ
Pediatric Clinics of North America - CIPERJ
Pediatric Clinics of North America - CIPERJ
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Pediatr Clin N Am 55 (2008) 339–355<br />
The Role <strong>of</strong> the Hematologist/Oncologist<br />
in the Care <strong>of</strong> Patients<br />
with Vascular Anomalies<br />
Denise M. Adams, MD a,b, *, Mary Sue Wentzel, RN b<br />
a Division <strong>of</strong> Hematology/Oncology, Cincinnati Children’s Hospital Medical Center, University<br />
<strong>of</strong> Cincinnati, MLC 7015, 3333 Burnet Avenue, Cincinnati, OH 45229, USA<br />
b Hemangioma and Vascular Malformation Center, Cincinnati Children’s Hospital<br />
Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA<br />
The proper care <strong>of</strong> children who have vascular anomalies requires the expertise<br />
<strong>of</strong> multiple pediatric specialists. In the past, there was much debate<br />
concerning the appropriate treatment <strong>of</strong> these lesions and which specialists<br />
needed to be involved. Many patients were evaluated by specialists who<br />
were confused about the diagnosis and the proper medical management.<br />
Because <strong>of</strong> the need for an interdisciplinary approach, several vascular<br />
anomalies centers have been developed across the world. These clinics are<br />
composed <strong>of</strong> specialists who have clinical acumen in surgery, radiology, dermatology,<br />
hematology, oncology, pathology, neurology, ophthalmology,<br />
cardiology, gastroenterology, and basic sciences. This comprehensive multidisciplinary<br />
approach <strong>of</strong>fers the best opportunity for children who have vascular<br />
anomalies to obtain optimal diagnostic and therapeutic management<br />
<strong>of</strong> these complex lesions.<br />
A classification system for vascular anomalies first was proposed in 1982<br />
by Mulliken and Glowacki [1]. This initial scheme distinguished hemangiomas<br />
from vascular malformations based on clinical appearance, histopathologic<br />
features, and biologic behavior. Hemangiomas were identified as<br />
vascular tumors with an active growth phase, characterized by endothelial<br />
proliferation and hypercellularity, followed by an involutional phase.<br />
Vascular malformations were described as congenital malformations <strong>of</strong><br />
the vasculature derived from capillaries, veins, lymphatic vessels, or arteries<br />
* Corresponding author. Division <strong>of</strong> Hematology/Oncology, Cincinnati Children’s<br />
Hospital Medical Center, University <strong>of</strong> Cincinnati, MLC 7015, 3333 Burnet Avenue,<br />
Cincinnati, OH 45229.<br />
E-mail address: denise.adams@cchmc.org (D.M. Adams).<br />
0031-3955/08/$ - see front matter. Published by Elsevier Inc.<br />
doi:10.1016/j.pcl.2008.01.007<br />
pediatric.theclinics.com